HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen Tan Selected Research

2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)

10/2021CNPase, a 2',3'-Cyclic-nucleotide 3'-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production.
1/2021Sirt3 increases CNPase enzymatic activity through deacetylation and facilitating substrate accessibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen Tan Research Topics

Disease

79Neoplasms (Cancer)
01/2022 - 05/2002
31Lung Neoplasms (Lung Cancer)
10/2019 - 05/2002
18Breast Neoplasms (Breast Cancer)
02/2021 - 09/2003
15Inflammation (Inflammations)
01/2022 - 08/2012
15Esophageal Squamous Cell Carcinoma
11/2021 - 08/2002
12Asthma (Bronchial Asthma)
02/2022 - 08/2006
12Carcinogenesis
10/2015 - 11/2002
11Neoplasm Metastasis (Metastasis)
01/2021 - 07/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 08/2005
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 08/2004
8Cardiomegaly (Heart Hypertrophy)
11/2021 - 01/2016
8Brain Ischemia (Cerebral Ischemia)
06/2020 - 01/2016
7Adenocarcinoma
11/2020 - 05/2002
7Stomach Neoplasms (Stomach Cancer)
04/2013 - 11/2004
6Ischemia
06/2020 - 01/2016
6Carcinoma (Carcinomatosis)
01/2017 - 10/2006
5Colitis
09/2022 - 01/2021
5Myocardial Ischemia (Ischemic Heart Diseases)
02/2022 - 01/2018
5Alzheimer Disease (Alzheimer's Disease)
05/2021 - 01/2017
5Hypertrophy
01/2020 - 11/2017
5Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 11/2005
5Stroke (Strokes)
01/2019 - 11/2017
5Genetic Predisposition to Disease (Genetic Predisposition)
01/2018 - 09/2005
4Hypoxia (Hypoxemia)
02/2022 - 01/2019
4Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 04/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 11/2002
4Heart Failure
10/2021 - 06/2004
4Fibrosis (Cirrhosis)
10/2021 - 11/2015
4Infections
01/2020 - 06/2009
4Pneumonia (Pneumonitis)
08/2019 - 08/2010
4Rectal Neoplasms (Rectal Cancer)
07/2019 - 04/2013
4Ischemic Stroke
01/2019 - 11/2017
4Esophageal Neoplasms (Esophageal Cancer)
07/2009 - 10/2004
3Body Weight (Weight, Body)
09/2022 - 01/2018
3Cardiomyopathies (Cardiomyopathy)
11/2021 - 01/2019
3Type 2 Diabetes Mellitus (MODY)
04/2021 - 02/2015
3Reperfusion Injury
01/2021 - 01/2018
3Neuroblastoma
06/2020 - 01/2013
3Ataxia Telangiectasia (Louis Bar Syndrome)
09/2015 - 08/2010
3Squamous Cell Carcinoma of Head and Neck
10/2014 - 01/2010
3Drug-Related Side Effects and Adverse Reactions
08/2014 - 09/2012
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2014 - 05/2008
3Adenocarcinoma of Lung
08/2010 - 11/2003
2Ulcerative Colitis
09/2022 - 01/2022
2Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 03/2017

Drug/Important Bio-Agent (IBA)

27isosteviolIBA
02/2022 - 01/2016
19SodiumIBA
01/2022 - 01/2016
16Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2008
14Pharmaceutical PreparationsIBA
09/2022 - 06/2013
13Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2008
10ORALIT (ORS)IBA
06/2015 - 11/2002
8Albuterol (Salbutamol)FDA LinkGeneric
09/2022 - 02/2014
8Therapeutic UsesIBA
01/2022 - 09/2017
8Biological ProductsIBA
10/2021 - 01/2008
8DNA (Deoxyribonucleic Acid)IBA
11/2017 - 10/2002
8PlatinumIBA
01/2014 - 04/2005
8EnzymesIBA
11/2011 - 05/2002
7furanodieneIBA
04/2017 - 01/2012
7CarcinogensIBA
05/2015 - 05/2002
6bambuterolIBA
02/2022 - 04/2015
6Messenger RNA (mRNA)IBA
01/2022 - 01/2017
6MicroRNAs (MicroRNA)IBA
06/2020 - 02/2011
6Neuroprotective AgentsIBA
06/2020 - 01/2016
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 06/2004
6Matrix Metalloproteinases (MMPs)IBA
01/2017 - 11/2002
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2009 - 08/2005
6Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2007 - 05/2002
6Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2005 - 11/2002
5CytokinesIBA
09/2022 - 04/2012
5NucleotidesIBA
10/2021 - 05/2002
5LipopolysaccharidesIBA
10/2021 - 05/2018
5Glucose (Dextrose)FDA LinkGeneric
04/2021 - 01/2011
5Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2021 - 11/2017
5LipidsIBA
01/2021 - 11/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 01/2016
5Folic Acid (Vitamin M)FDA LinkGeneric
01/2007 - 05/2002
4Paclitaxel (Taxol)FDA LinkGeneric
12/2019 - 06/2014
4CaspasesIBA
03/2016 - 05/2007
4LigandsIBA
01/2016 - 07/2004
3Dinoprostone (PGE2)FDA Link
10/2021 - 11/2017
3Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 01/2019
3Bronchodilator Agents (Bronchodilators)IBA
01/2020 - 01/2018
3Peptides (Polypeptides)IBA
01/2020 - 08/2014
3SmokeIBA
01/2019 - 05/2009
3BerberineIBA
01/2015 - 01/2011
3Genetic Markers (Genetic Marker)IBA
10/2014 - 06/2009
3HLA Antigens (Human Leukocyte Antigens)IBA
08/2014 - 09/2012
3Cisplatin (Platino)FDA LinkGeneric
06/2014 - 08/2004
3AntigensIBA
01/2014 - 05/2007
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2010 - 11/2003
3Fas Ligand Protein (Fas Ligand)IBA
05/2008 - 07/2004
3Thymidylate SynthaseIBA
01/2007 - 08/2005
3ADP Ribose Transferases (ADP Ribosyltransferase)IBA
08/2006 - 02/2005
2Dextran SulfateIBA
09/2022 - 01/2022

Therapy/Procedure

19Therapeutics
10/2021 - 01/2011
19Drug Therapy (Chemotherapy)
01/2020 - 08/2004
7Radiotherapy
01/2021 - 10/2010
4Chemoradiotherapy
07/2019 - 07/2011
3Injections
01/2019 - 01/2016
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2016 - 03/2012